10月22日，再鼎医药（HK9688）(09688.HK)盘中跌超5%，截至9时34分，跌5.26%，报18.74港元/股，成交额506.01万港元。消息面上，10月21日，前三季度创新药（886015）对外技术授权约1300亿美元接近去年全年，2026年ESMO大会共有29项中国创新药（886015）研究入选最新突破性摘要创历史新高。券商指出创新药（886015）出海政策边界明确，技术目录调整...
Source Link10月22日，再鼎医药（HK9688）(09688.HK)盘中跌超5%，截至9时34分，跌5.26%，报18.74港元/股，成交额506.01万港元。消息面上，10月21日，前三季度创新药（886015）对外技术授权约1300亿美元接近去年全年，2026年ESMO大会共有29项中国创新药（886015）研究入选最新突破性摘要创历史新高。券商指出创新药（886015）出海政策边界明确，技术目录调整...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.